Your browser doesn't support javascript.
loading
Characterization of patients with extensive left atrial myopathy referred for atrial fibrillation ablation: incidence, predictors, and outcomes.
González-Ferrero, Teba; Bergonti, Marco; Marcon, Lorenzo; Minguito-Carazo, Carlos; Tilves Bellas, Carlos; Pesquera Lorenzo, Juan Carlos; Martínez-Sande, José Luis; González-Melchor, Laila; García-Seara, Francisco Javier; Fernández-López, Jesús Alberto; González-Juanatey, José Ramón; Heidbuchel, Hein; Sarkozy, Andrea; Rodríguez-Mañero, Moisés.
Affiliation
  • González-Ferrero T; Division of Cardiac Electrophysiology, Department of Cardiology, University Hospital Lucus Augusti, Lugo, Spain.
  • Bergonti M; Translational Cardiology Group, Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Travesía da Choupana S/N, 15706, Santiago de Compostela, A Coruña, Spain.
  • Marcon L; CIBERCV, Institute of Health Carlos III, Madrid, Spain.
  • Minguito-Carazo C; Cardiovascular Area and Coronary Unit, University Clinical Hospital of Santiago de Compostela, Santiago de Compostela, Spain.
  • Tilves Bellas C; Division of Cardiology, Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale, 6900, Lugano, Switzerland.
  • Pesquera Lorenzo JC; Department of Cardiology, University Hospital Antwerp, Antwerp, Belgium.
  • Martínez-Sande JL; Cardiovascular Research, GENCOR, University of Antwerp, Antwerp, Belgium.
  • González-Melchor L; Translational Cardiology Group, Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Travesía da Choupana S/N, 15706, Santiago de Compostela, A Coruña, Spain.
  • García-Seara FJ; CIBERCV, Institute of Health Carlos III, Madrid, Spain.
  • Fernández-López JA; Cardiovascular Area and Coronary Unit, University Clinical Hospital of Santiago de Compostela, Santiago de Compostela, Spain.
  • González-Juanatey JR; Translational Cardiology Group, Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Travesía da Choupana S/N, 15706, Santiago de Compostela, A Coruña, Spain.
  • Heidbuchel H; Division of Cardiac Electrophysiology, Department of Cardiology, University Hospital Lucus Augusti, Lugo, Spain.
  • Sarkozy A; Translational Cardiology Group, Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Travesía da Choupana S/N, 15706, Santiago de Compostela, A Coruña, Spain.
  • Rodríguez-Mañero M; CIBERCV, Institute of Health Carlos III, Madrid, Spain.
Clin Res Cardiol ; 2024 Jun 26.
Article in En | MEDLINE | ID: mdl-38922425
ABSTRACT

BACKGROUND:

Although atrial fibrosis has a relevant impact on ablation success rate, experimental studies have reported that extensive fibrosis may be accompanied by a reduced burden secondary to a prominent depression of atrial excitability.

OBJECTIVES:

We aimed to identify clinical and echocardiographic factors associated with extensive left atrial myopathy (ELAM), to analyze the predictive ability of established scores (AF score, APPLE, and DR-FLASH) and assess outcomes in terms of AF recurrence, left atrial flutter, and post-procedural heart failure admissions.

METHODS:

A total of 950 consecutive patients undergoing the first AF ablation were included. A 3D electroanatomical mapping system (CARTO3, Biosense Webster) was created using a multipolar mapping catheter (PentaRay, Biosense Webster). ELAM was defined as ≥ 50% low voltage area. A subanalysis with four groups was also created (< 10%; 10-20%; 10-20%; and > 30%). Logistic regressions, Cox proportional hazards models, and log-rank test were used to test the predictors independently associated with the presence of ELAM and AF recurrence. The model was prospectively validated in a cohort of 150 patients obtaining an excellent ability for prediction AUC 0.90 (CI 95% 0.84-0.96).

RESULTS:

Overall, 78 (8.42%) presented ELAM. Age, female sex, persistent AF, first-degree AV block, and E/e' were significant predictors. The model incorporating these factors outperformed the existing scores (AUC = 0.87). During a mean follow-up of 20 months (IQR 9 to 36), patients with ELAM presented a higher rate of AF recurrence (42.02% vs 26.01%, p = 0.030), left atrial flutter (26.03% vs 8.02%, p < 0.001), and post-procedural heart failure admissions (12.01% vs 0.61%, p < 0.001) than non-ELAM patients.

CONCLUSIONS:

This study reveals the incidence and clinical factors associated with ELAM in AF, highlighting age, female, persistent AF, first-degree AV block, and E/e'. Importantly, the presence of ELAM is associated with poorer outcomes in terms of recurrence and HF admission.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Clin Res Cardiol Journal subject: CARDIOLOGIA Year: 2024 Document type: Article Affiliation country: Spain

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Clin Res Cardiol Journal subject: CARDIOLOGIA Year: 2024 Document type: Article Affiliation country: Spain